Cell Harvesting System Market Size, Share & Trends Analysis Report By Application (Umbilical Cord, Bone marrow, Peripheral Blood, Adipose Tissue), By End Use (Hospitals, Clinics, R&D Centers), And Segment Forecasts, 2018 - 2025

Report Overview

The global cell harvesting systems market size was valued USD 3.17 billion in 2016 and is expected to grow at a CAGR of 13.9% over the forecast period. Major factors driving the growth of this industry are increasing demand for stem cell-based therapy and rising investment in clinical research, owing to its potential benefits in regenerative medicine.

Increasing aging population and rising prevalence of chronic conditions, such as cardiovascular diseases, are further expected to contribute to the demand for stem cell-based therapy, thereby propelling the market. There has been a significant rise in stem cell-based research over the past decade, which is driving the demand for stem cell harvesting for research. For instance, the National Institutes of Health (NIH), a primary agency for biomedical and public healthcare research in the U.S., invested USD 1.49 billion in stem cell research in 2016, which was an increase of approximately 5.0% from 2015.

The rising transplantation rate and growing demand for stem cell banking are also some of the factors responsible for the rising requirement of harvesting across the globe. The new sources of stem cells, such as umbilical cord, adipose tissue, and embryonic stem cells, exhibit tremendous potential for cancer treatment and development of regenerative products, which drives research associated with these sources.

However, ethical issues related to embryonic stem cells and unapproved stem cell therapy provided by healthcare providers in unregulated regions such as Latin America and Asia Pacific are expected to limit the growth of this market over the forecast period.

Application Insights

This technique is used to retrieve stem cells from umbilical cord, bone marrow, peripheral blood, adipose tissue, and other sources. The peripheral blood segment held the largest market share in 2016 and is expected to maintain it over the forecast period. This can be attributed to the high use of peripheral blood in stem cell transplants and the growing use of peripheral blood in stem cell research.

Adipose tissue is expected to witness the fastest growth owing to the retrieval of a higher number of stem cells from liposuction and their potential use in regenerative medicine. Umbilical cord is also expected to witness lucrative growth owing to its increasing use in transplantation and potential use in other therapies.

End-use Insights

On the basis of end-use, the market is segmented into hospitals, clinics, academic institutes, and R&D centers. Hospitals held the largest share and is expected to continue the dominance over the forecast period, as the majority of stem cell harvesting for transplantation & research is undertaken in hospitals.

Academic institutes and R&D centers are expected to witness the fastest growth, owing to growing investment in research by universities and biopharmaceutical companies. Rising demand for regenerative medicine and stem cell-based therapies is further expected to contribute toward the growth of research in academic institutes and R&D centers.

Regional Insights

Europe and North America spearheaded the market as of 2016, by contributing over 74.0% to the overall revenue. The majority of stem cell transplants are conducted in Europe, and it is one of the major factors contributing to the lucrative share in the cell harvesting system market.

In 2016, North America dominated the research landscape as more than 54.0% of stem cell clinical trials were conducted in this region. The region also accounts for the second-largest number of stem cell transplantation, which is further driving the demand for harvesting in the region.

Asia Pacific is anticipated to witness lucrative growth over the forecast period, owing to the rising incidence of chronic diseases and increasing demand for stem cell transplantation along with stem cell-based therapy. Japan and China are the biggest markets for harvesting systems in Asia Pacific. Emerging countries such as Mexico, South Korea, and South Africa are also expected to report lucrative growth over the forecast period. Growing investment by government bodies on stem cell-based research and an increase in the aging population can be attributed to the increasing demand for these therapies in these countries.

Cell Harvesting System Market Share Insights

Primary participants profiled for the market are Argos Technologies, Inc.; Perkin Elmer, Inc.; Brand GmBh + CO KG; Arthrex, Inc.; Avita Medical; Tomtec; Terumo Corporation; Teleflex, Inc.; and Bertin.

Companies such as Terumo Corporation offer a wide range of products including apheresis systems and harvesters. In September 2016, Terumo BCT formed a strategic collaboration with Cognate Bioservices-a bioservice contract organization-for developing immunotherapy and other related products and increasing the use of the quantum systems in manufacturing cell therapy products.

Cell Harvesting System Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global cell harvesting system market on the basis of application, end use, and region:

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Umbilical Cord

  • Bone Marrow

  • Peripheral Blood

  • Adipose tissue

  • Other sources

• End-use Outlook (Revenue, USD Million, 2014 - 2025)

  • Hospitals

  • Clinics

  • Academic institutes

  • R&D centers

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • Japan

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

    • Saudi Arabia